![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2023-05/FrontLineHead.Blanke.2022-web-sized_0.png?itok=UsajR0il)
May 15, 2023
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2023-05/FrontLineHead.Blanke.2022-web-sized.png?itok=ag1aRtOQ)
May 5, 2023
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2023-04/FrontLineHead.Blanke.2022-web-sized_3.png?itok=ezT0ofLq)
Apr 28, 2023
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2023-04/FrontLineHead.Blanke.2022-web-sized_2.png?itok=A_YMh6GJ)
Apr 21, 2023
![S1609 DART gynecologic cancer results at AACR 2023](/sites/default/files/styles/news_recent/public/news/2023-04/press-card-S1609-Chae-AACR-725x415.png?itok=xSBcygcf)
Apr 17, 2023
SWOG researchers report results in rare gynecologic cancers from S1609 DART immunotherapy trial
![S1512 Cohort B results at AACR 2023](/sites/default/files/styles/news_recent/public/news/2023-04/press-card-S1512-Kendra-AACR-725x415.png?itok=oSZ1xMr4)
Apr 16, 2023
SWOG S1512 trial sees high response rate to pembrolizumab in patients with unresectable desmoplastic melanoma
![SWOG Front Line banner](/sites/default/files/styles/news_recent/public/news/2023-04/FrontLineHead.Blanke.2022-web-sized_1.png?itok=gEm3InPY)
Apr 14, 2023
![S2302 Pragmatica-Lung trial](/sites/default/files/styles/news_recent/public/news/2023-04/Pragmatica-Lung.FINAL_.20230412-725x415.png?itok=rdrOISYI)
Apr 12, 2023
SWOG S2302 Pragmatica-Lung study opens to enrollment, a model for easier, more representative clinical trials